On Wednesday, the UAE Health Ministry testified that Sinopharm’s vaccine has shown 86 percent effectiveness against the global virus.
Sinopharm is a China-based Pharmaceutical group, and it’s vaccine’s latest results are based on the analysis from its late-stage trial in the UAE.
The UAE has registered the vaccine; however, none of its detailed data on its effective results were shared, neither by China nor by UAE.
![](https://wonderfulengineering.com/wp-content/uploads/2020/12/Sinopharm-Covid-19-vaccine-2A.jpg)
The Sinopharm vaccine saw emergency approval in September to be put to use for certain vulnerable groups. It marked the first time that a vaccine from China got global clearance. It is one of the three top vaccines produced in China, and approximately 1 million people have been vaccinated.
![](https://wonderfulengineering.com/wp-content/uploads/2020/12/Sinopharm-Covid-19-vaccine-2B-1.jpg)
Although having quite an impressive curing percentage, the Sinopharm vaccine still falls short of Russian-produced Sputnik V that has shown 92 percent effectiveness. The Moderna’s vaccine has shown 100 percent effectiveness with certain vulnerable groups. While another vaccine by Pfizer/BioNTech’s has shown 95 percent efficacy to protect against the Covid-19.
The latest analysis of the Sinopharm vaccine showed that 99 percent of participants developed antibodies against the Covid-19. Moreover, the vaccine is based on an inactivated virus.
![](https://wonderfulengineering.com/wp-content/uploads/2020/12/Sinopharm-Covid-19-vaccine-3-1024x576.jpeg)